264 related articles for article (PubMed ID: 21198543)
1. Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.
Klose C; Straub I; Riehle M; Ranta F; Krautwurst D; Ullrich S; Meyerhof W; Harteneck C
Br J Pharmacol; 2011 Apr; 162(8):1757-69. PubMed ID: 21198543
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels.
Chen GL; Zeng B; Eastmond S; Elsenussi SE; Boa AN; Xu SZ
Br J Pharmacol; 2012 Nov; 167(6):1232-43. PubMed ID: 22646516
[TBL] [Abstract][Full Text] [Related]
3. Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels.
Jiang H; Zeng B; Chen GL; Bot D; Eastmond S; Elsenussi SE; Atkin SL; Boa AN; Xu SZ
Biochem Pharmacol; 2012 Apr; 83(7):923-31. PubMed ID: 22285229
[TBL] [Abstract][Full Text] [Related]
4. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs.
Hu H; Tian J; Zhu Y; Wang C; Xiao R; Herz JM; Wood JD; Zhu MX
Pflugers Arch; 2010 Mar; 459(4):579-92. PubMed ID: 19888597
[TBL] [Abstract][Full Text] [Related]
5. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3.
Straub I; Mohr F; Stab J; Konrad M; Philipp SE; Oberwinkler J; Schaefer M
Br J Pharmacol; 2013 Apr; 168(8):1835-50. PubMed ID: 23190005
[TBL] [Abstract][Full Text] [Related]
6. Control of Insulin Release by Transient Receptor Potential Melastatin 3 (TRPM3) Ion Channels.
Becker A; Mannebach S; Mathar I; Weissgerber P; Freichel M; Loodin AP; Fecher-Trost C; Belkacemi A; Beck A; Philipp SE
Cell Physiol Biochem; 2020 Nov; 54(6):1115-1131. PubMed ID: 33166100
[TBL] [Abstract][Full Text] [Related]
7. Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1.
Becker A; Götz C; Montenarh M; Philipp SE
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884938
[TBL] [Abstract][Full Text] [Related]
8. Activation and inhibition of transient receptor potential TRPM3-induced gene transcription.
Lesch A; Rubil S; Thiel G
Br J Pharmacol; 2014 May; 171(10):2645-58. PubMed ID: 24895737
[TBL] [Abstract][Full Text] [Related]
9. Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release.
Held K; Kichko T; De Clercq K; Klaassen H; Van Bree R; Vanherck JC; Marchand A; Reeh PW; Chaltin P; Voets T; Vriens J
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1363-72. PubMed ID: 25733887
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
Greenwood IA; Large WA
Br J Pharmacol; 1995 Dec; 116(7):2939-48. PubMed ID: 8680728
[TBL] [Abstract][Full Text] [Related]
11. Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.
Straub I; Krügel U; Mohr F; Teichert J; Rizun O; Konrad M; Oberwinkler J; Schaefer M
Mol Pharmacol; 2013 Nov; 84(5):736-50. PubMed ID: 24006495
[TBL] [Abstract][Full Text] [Related]
12. The potential and promise of mefenamic acid.
Cimolai N
Expert Rev Clin Pharmacol; 2013 May; 6(3):289-305. PubMed ID: 23656341
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction via TRPM3 channels in pancreatic β-cells.
Thiel G; Müller I; Rössler OG
J Mol Endocrinol; 2013 Jun; 50(3):R75-83. PubMed ID: 23511953
[TBL] [Abstract][Full Text] [Related]
14. Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABA
Mansikkamäki S; Sinkkonen ST; Korpi ER; Lüddens H
Eur J Pharmacol; 2019 Jun; 853():247-255. PubMed ID: 30930251
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endothelial cell Ca²⁺ entry and transient receptor potential channels by Sigma-1 receptor ligands.
Amer MS; McKeown L; Tumova S; Liu R; Seymour VA; Wilson LA; Naylor J; Greenhalgh K; Hou B; Majeed Y; Turner P; Sedo A; O'Regan DJ; Li J; Bon RS; Porter KE; Beech DJ
Br J Pharmacol; 2013 Mar; 168(6):1445-55. PubMed ID: 23121507
[TBL] [Abstract][Full Text] [Related]
16. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
Kankaanranta H; Moilanen E; Vapaatalo H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
[TBL] [Abstract][Full Text] [Related]
17. Primidone inhibits TRPM3 and attenuates thermal nociception in vivo.
Krügel U; Straub I; Beckmann H; Schaefer M
Pain; 2017 May; 158(5):856-867. PubMed ID: 28106668
[TBL] [Abstract][Full Text] [Related]
18. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells.
Son GY; Yang YM; Park WS; Chang I; Shin DM
J Dent Res; 2015 Mar; 94(3):473-81. PubMed ID: 25595364
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
20. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
